Question 1

What is Oryzon Genomics?

Accepted Answer

Oryzon Genomics is a Company.

Question 2

How often does Oryzon Genomics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Oryzon Genomics first tracked by Ergen?

Accepted Answer

First tracked on May 14, 2026.

Question 4

When was Oryzon Genomics last mentioned in news?

Accepted Answer

Last active on Jul 09, 2026.

Question 5

What is Oryzon Genomics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 45 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Oryzon Genomics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Oryzon Genomics?

Accepted Answer

Oryzon Genomics Q1 2026 Results, Drug Progress (May 14, 2026, 6 articles).

Question 8

How did the "Oryzon Genomics Q1 2026 Results, Drug Progress" event impact Oryzon Genomics?

Accepted Answer

Oryzon Genomics reported positive financial results for Q1 2026 and provided updates on its clinical development programs, particularly for iadademstat and vafidemstat, which are showing encouraging clinical data and advancing through trials.

Question 9

How did the "Oryzon gets US patent for vafidemstat in BPD" event impact Oryzon Genomics?

Accepted Answer

Oryzon is the patent holder and beneficiary; the patents strengthen its IP portfolio and support vafidemstat's commercial potential.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.